
Loading, please wait...

Loading, please wait...

Recently, researchers updated the VUMC algorithm for sickle cell disease identification to support gene therapy trials. Additionally, this automated tool utilizes electronic health record (EHR) data to create contemporaneous cohorts. Consequently, clinicians can compare outcomes between treated and untreated individuals. Historically, identifying these cohorts manually required significant resources. However, the updated algorithm streamlines this process with remarkable precision.
In this study, researchers evaluated 33,141 individuals of primarily African ancestry. Notably, the prevalence of SCD in this cohort was 1.4%. As a result, the VUMC algorithm demonstrated a sensitivity of 97.6% and a specificity of 99.9%. Furthermore, the positive predictive value (PPV) reached 98.9%. These metrics confirm the algorithm's reliability for large-scale clinical research.
Moreover, the tool distinguishes between specific SCD phenotypes. For instance, it achieved 96.8% sensitivity for HbSS/HbSβ0. In contrast, the sensitivity for HbSβ+ was 85%. Despite these variations, the specificity remained consistently high at 99.9% across all groups.
Therefore, accurate sickle cell disease identification is vital for evaluating newly approved gene therapies. Moreover, researchers need robust datasets to monitor long-term outcomes effectively. Therefore, this algorithm provides a scalable solution for healthcare systems globally. Ultimately, it enables the creation of high-fidelity cohorts without exhaustive manual chart reviews.
The algorithm uses a combination of ICD codes and laboratory data from electronic health records to identify and categorize patients with sickle cell disease.
The updated VUMC algorithm identifies the HbSS/HbSβ0 phenotype with a sensitivity of 96.8% and maintains a specificity of 99.9%.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Learn how the updated VUMC algorithm identifies sickle cell disease with >97% sensitivity using EHR data, aiding gene therapy outcome monitoring....
6 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today